Developer docs
API playgroundTry for free, no card

Search company profiles

American Society of Clinical Psychopharmacology

Full company profile

uuid00bzpt6

Namestring
American Society of Clinical Psychopharmacology
Legal namestring
American Society of Clinical Psychopharmacology
Websiteurl
ascpp.org
Company typeenum
Private
Founded yearint
1992
Descriptiontext

The American Society of Clinical Psychopharmacology (ASCP), founded in 1992 and headquartered in Brentwood, Tennessee, is a nonprofit professional society advancing the science, practice, and education of clinical psychopharmacology. It serves psychiatrists, doctoral-level investigators, early-career researchers, and pharmaceutical industry/regulatory professionals, with a stated membership of over 900 across 50+ countries. The organization operates the field's premier annual scientific gathering (formerly NCDEU, rebranded as the ASCP Annual Meeting in 2006), which in 2025 drew 958 attendees including academic investigators, research pharmacists, clinicians, and federal regulators. ASCP owns the official Journal of Clinical Psychiatry (largest circulation in psychiatry, published by Physicians Postgraduate Press), the Model Curriculum in Psychopharmacology widely used across U.S. residency programs since 1997, and the February 2026 Deprescribing Consensus Statement published in JAMA Network Open.

ASCP's product portfolio spans in-person convening, peer-reviewed publishing, podcast content (Psychopharm Today with Psychiatric Times), an Interactive AI Curriculum in Psychopharmacology (delivered via partner platform edyou.com), and structured programs including the New Investigator Award Program, Nina Schooler Early Career Research Award ($7,500), Donald Klein Lifetime Achievement Award, and the ACTIVE (Alcohol Clinical Trials Initiative) workgroup. The society publishes ASCP Corner articles in JCP, 5 Minute Pearls video series, and Problem-Based Learning cases.

Revenue mechanics rest on three pillars: tiered membership dues ($125 Regular, $94 Associate, free for Residents/Trainees with multi-year and developing-country discounts), Annual Meeting registration fees and Platinum/Gold/Silver corporate sponsorships, and transactional sales of educational products including the AI Curriculum. A small staff of 1-10 employees supports operations, with management company Parthenon Management (Lindsay Snyder, [email protected]) handling administration. ASCP holds no external funding rounds, parent company, or subsidiaries; it operates as a member-supported autonomous nonprofit under a Board of Directors structure established via 2005 bylaws reform.

Short descriptiontext

ASCP is a 900+-member nonprofit professional society founded in 1992 that advances clinical psychopharmacology through its Annual Meeting, official Journal of Clinical Psychiatry, Model Curriculum, and consensus initiatives, serving psychiatrists, researchers, and federal/industry stakeholders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBrentwood, United States
HQ citystring
Brentwood
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical psychopharmacology research, medical professional society, psychiatric education programs, continuing medical education, clinical trial research
Industry3 codes
PRIMARYEDADACAF
Continuing Education (CE/CPD) & Provider Accreditation Bodies
Education/Education Administration, Accreditation & Policy/Accreditation Bodies (Institutional & Programmatic)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training
SECONDARYMPACALAI
Certification & Credentialed Creator Programs
NAICS code2 codes
  • Colleges, Universities, and Professional Schools6113
  • Computer Training611420
SIC code2 codes
  • Services-Membership Organizations8600
  • Services-Educational Services8200
Product category
Professional Medical Society (Clinical Psychopharmacology)
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Membership Dues
TypeSubscription Recurring
Description

ASCP generates revenue through annual membership dues at tiered rates: $125 for Regular Membership, $94 for Associate Membership, and complimentary for Residents/Trainees. Multi-year renewals offer 5% off three-year and 10% off five-year commitments. Member referral program provides $10 discount for both referrer and new member.

ascpp.org
2Annual Meeting Registration and Sponsorships
TypeSubscription Recurring
Description

The ASCP Annual Meeting generates revenue through attendee registration fees (with discounted rates for members) and corporate sponsorships. The 2025 meeting had 958 total attendees with representation from academic, research, industry, and clinical sectors. Sponsorships range from Platinum to Silver levels.

ascpp.org
3Educational Products and Publications
TypeSubscription Recurring
Description

ASCP sells educational products including the Interactive AI Curriculum in Psychopharmacology. The society's official journal The Journal of Clinical Psychiatry provides member subscriptions (valued at $199) as a membership benefit, with circulation managed through Physicians Postgraduate Press.

ascpp.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details6 tiers
1Regular Membership for doctoral-level professionals
ModelSubscriptionBilling cadenceAnnual
Notes

$125 annual dues. Full privileges including eligibility for office and voting.

ascpp.org
2Associate Membership for non-doctoral professionals
ModelSubscriptionBilling cadenceAnnual
Notes

$94 annual dues. Not eligible for office, to vote, or to Chair/Co-Chair Committees.

ascpp.org
3Resident/Trainee Membership
ModelFreemiumBilling cadenceAnnual
Notes

Complimentary (free). Verification of enrollment required. Resident/trainee members can receive a 50% discount on their first year of ASCP membership after completion of training.

ascpp.org
4Fellow Membership recognition
ModelSubscriptionBilling cadenceAnnual
Notes

No additional fee. Achieved by maintaining membership for at least 10 years with 5 Annual Meeting attendances, OR 20 years of membership.

ascpp.org
5Multi-Year Renewal Discounts
ModelSubscriptionBilling cadenceMulti-year contract
Notes

5% off a three-year renewal; 10% off a five-year renewal. Contact Executive Office to renew.

ascpp.org
6Developing Countries Membership Rate
ModelSubscriptionBilling cadenceAnnual
Notes

Class A: $125; Class B: $105; Class C: $78; Class D: $51. Based on World Bank GDP classification. Requires residency, current living, and citizenship in qualifying country.

ascpp.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 12 records shown
1The Journal of Clinical Psychiatry
Description

ASCP's official journal with the largest circulation in psychiatry, published by Physicians Postgraduate Press (PPP).

ascpp.org
+11 more records
Core offering1 text field

ASCP is a nonprofit professional medical society that advances the science, practice, and education of clinical psychopharmacology. It sells tiered individual memberships and delivers continuing education through its flagship Annual Meeting, the Interactive AI Curriculum in Psychopharmacology for psychiatry residents, the Journal of Clinical Psychiatry, podcasts, problem-based learning modules, clinical trials resources, and award programs for early-career investigators.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 45 international experts achieved consensus on 63% of evaluated clinical scenarios in landmark deprescribing study
+1 more record
Product overview1 text field

The American Society of Clinical Psychopharmacology (ASCP) is a professional membership organization rather than a software product company. ASCP offers a portfolio of educational and professional development services centered around advancing clinical psychopharmacology. Core offerings include the ASCP Annual Meeting (the premier psychopharmacology conference), the ASCP Interactive AI Curriculum for psychiatry residency training, the Psychopharm Today Podcast (collaboration with Psychiatric Times), and the Find a Psychopharmacologist Database. Additional services include the ASCP Job Board, Clinical Trials Support with trial listings, The Journal of Clinical Psychiatry (official journal with ASCP Corner), 5 Minute Pearls video series, Problem-Based Learning cases, the Nina Schooler Early Career Research Award ($7,500), the New Investigator Award Program, the Alcohol Clinical Trials Initiative (ACTIVE), and the ASCP Deprescribing Consensus Statement. The society does not offer a unified software product platform but provides these professional resources and educational materials to its over 900 members.

Product and service2 records
1ASCP Membership
CategoryMembership
2ASCP Annual Meeting
CategoryConference and Events
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1The Journal of Clinical Psychiatry (Physicians Postgraduate Press)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Journal of Clinical Psychiatry, published by Physicians Postgraduate Press (PPP), is ASCP's official journal with the largest circulation in psychiatry. Each month the Journal features the 'ASCP Corner.' Current ASCP members receive a free online subscription to the JCP as part of their membership.

ascpp.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ASCP is a proud member of the American Brain Coalition (ABC), supporting advocacy for brain research and neurological and psychiatric disorders.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

ASCP participated in developing a portion of ACNP's annual meeting, emphasizing the science of clinical psychopharmacology. ASCP took over development of the ACNP curriculum for residents in psychopharmacology in 1997, which is now widely used in the U.S. and internationally.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ASCP is joined by NIMH to organize the Annual Meeting program that emphasizes presentation of information not previously published or presented. NIMH representatives participate in the Program Committee.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ASCP collaborates with NIDA on the Annual Meeting program and participates in the Clinical Trials Workshop sponsored in conjunction with NIMH and Zucker Hillside Hospital.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ASCP partners with NIAAA on the Annual Meeting program, with NIAAA representatives included in program planning and federal agency updates.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

FDA representatives participate in the ASCP Annual Meeting Program Committee, with the FDA Center for Drug Evaluation and Research having dedicated representation. FDA regulatory perspectives are featured in meeting sessions.

8ACTIVE (Alcohol Clinical Trials Initiative) Supporters
Strategic tierMajorTypeStrategic or Co-development Partner
Description

ACTIVE workgroup includes two representatives from each supporting corporation, FDA, NIDA, academic experts, and NIAAA consultation. Current supporters: Imbrium, Lilly. Past supporters include Abbott, Alkermes, Arbor Pharmaceuticals, Dicerna, Ethypharm, GlaxoSmithKline, Indivior, Janssen, Kinnov Therapeutics, Lundbeck, Mitsubishi Tanabe Pharma, Otsuka, Pear Therapeutics, Pfizer, Schering Plough.

ascpp.org
Strategic tierMajorTypeGTM or Marketing Partner
Description

ASCP partners with Psychiatric Times on the Psychopharm Today podcast, expanding offerings and bringing expert-driven conversations to the community. Members can opt for free Psychiatric Times delivery.

10International Foundation for Research and Education on Depression (iFred)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

iFred (depression.org), led by ASCP founder Dr. Paul Wender, shares educational information on depression. ASCP links to iFred resources from its patient information section.

ascpp.org
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Sub-specialty psychiatry society with comparable membership, CME, and annual meeting structure to ASCP, though focused on a different patient population (children/adolescents).

2European College of Neuropsychopharmacology (ECNP)
TypeRegional player
Description

European counterpart to ACNP/ASCP focused on neuropsychopharmacology research and education. Comparable membership society model with annual scientific meeting and educational programs; primarily Europe-based.

3International Society for Affective Disorders (ISAD)
TypeEmerging player
Description

Scientific society focused on mood disorders — a condition class central to ASCP's clinical content (deprescribing consensus covers antidepressants). Comparable academic society model but narrower scope.

TypeOthers
Description

Large internal medicine society whose CME/CE infrastructure and journal model (Annals of Internal Medicine) parallels the operational template ASCP uses for the Journal of Clinical Psychiatry membership benefit.

TypeDirect peer
Description

The closest direct peer to ASCP — both are physician-led scientific societies advancing psychopharmacology and neuropsychopharmacology. ACNP actually handed off Model Curriculum development to ASCP in 1997, evidencing tight functional overlap.

TypeDirect peer
Description

Scientific society for biological psychiatry with overlapping membership of clinical investigators and psychiatrists focused on pharmacology and treatment research. Comparable annual scientific meeting and journal model.

7International College of Neuropsychopharmacology (CINP)
TypeDirect peer
Description

Global scientific organization for neuropsychopharmacology. Comparable to ASCP in mission and target membership (psychiatrists and clinical investigators), with international rather than U.S.-centric focus.

TypeDirect peer
Description

Honor-focused psychiatric professional society emphasizing education, research, and clinical excellence — overlapping strongly with ASCP's education-and-consensus mission and target audience of senior psychiatrists.

TypeEmerging player
Description

Patient-and-professional organization with overlapping focus on psychopharmacology of anxiety/depression. Smaller and less academic than ASCP, but addresses the same therapeutic conditions ASCP's consensus work covers.

TypeBroad incumbent
Description

The dominant U.S. professional society for psychiatry at large. Overlaps with ASCP through CME/CE, clinical guidelines, and Annual Meeting programming, but covers all of psychiatry rather than just psychopharmacology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

American Society of Clinical Psychopharmacology

Professional Medical Society (Clinical Psychopharmacology)ascpp.org

ASCP is a 900+-member nonprofit professional society founded in 1992 that advances clinical psychopharmacology through its Annual Meeting, official Journal of Clinical Psychiatry, Model Curriculum, and consensus initiatives, serving psychiatrists, researchers, and federal/industry stakeholders.

What American Society of Clinical Psychopharmacology does

The American Society of Clinical Psychopharmacology (ASCP), founded in 1992 and headquartered in Brentwood, Tennessee, is a nonprofit professional society advancing the science, practice, and education of clinical psychopharmacology. It serves psychiatrists, doctoral-level investigators, early-career researchers, and pharmaceutical industry/regulatory professionals, with a stated membership of over 900 across 50+ countries. The organization operates the field's premier annual scientific gathering (formerly NCDEU, rebranded as the ASCP Annual Meeting in 2006), which in 2025 drew 958 attendees including academic investigators, research pharmacists, clinicians, and federal regulators. ASCP owns the official Journal of Clinical Psychiatry (largest circulation in psychiatry, published by Physicians Postgraduate Press), the Model Curriculum in Psychopharmacology widely used across U.S. residency programs since 1997, and the February 2026 Deprescribing Consensus Statement published in JAMA Network Open.

ASCP's product portfolio spans in-person convening, peer-reviewed publishing, podcast content (Psychopharm Today with Psychiatric Times), an Interactive AI Curriculum in Psychopharmacology (delivered via partner platform edyou.com), and structured programs including the New Investigator Award Program, Nina Schooler Early Career Research Award ($7,500), Donald Klein Lifetime Achievement Award, and the ACTIVE (Alcohol Clinical Trials Initiative) workgroup. The society publishes ASCP Corner articles in JCP, 5 Minute Pearls video series, and Problem-Based Learning cases.

Revenue mechanics rest on three pillars: tiered membership dues ($125 Regular, $94 Associate, free for Residents/Trainees with multi-year and developing-country discounts), Annual Meeting registration fees and Platinum/Gold/Silver corporate sponsorships, and transactional sales of educational products including the AI Curriculum. A small staff of 1-10 employees supports operations, with management company Parthenon Management (Lindsay Snyder, [email protected]) handling administration. ASCP holds no external funding rounds, parent company, or subsidiaries; it operates as a member-supported autonomous nonprofit under a Board of Directors structure established via 2005 bylaws reform.

American Society of Clinical Psychopharmacology firmographics

Firmographics
Name
American Society of Clinical Psychopharmacology
Legal name
American Society of Clinical Psychopharmacology
Website
https://ascpp.org
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
1–10 employees
Short description
ASCP is a 900+-member nonprofit professional society founded in 1992 that advances clinical psychopharmacology through its Annual Meeting, official Journal of Clinical Psychiatry, Model Curriculum, and consensus initiatives, serving psychiatrists, researchers, and federal/industry stakeholders.
Ownership category
akta.pro rank

American Society of Clinical Psychopharmacology industry classification

Industry
Product category
Professional Medical Society (Clinical Psychopharmacology)
NAICS
Colleges, Universities, and Professional Schools (6113), Computer Training (611420)
SIC
Services-Membership Organizations (8600), Services-Educational Services (8200)
akta.pro industry
PRIMARYEDADACAF
Continuing Education (CE/CPD) & Provider Accreditation Bodies
Education/Education Administration, Accreditation & Policy/Accreditation Bodies (Institutional & Programmatic)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training
SECONDARYMPACALAI
Certification & Credentialed Creator Programs

Keywords

  • Clinical psychopharmacology research
  • Medical professional society
  • Psychiatric education programs
  • Continuing medical education
  • Clinical trial research

Where American Society of Clinical Psychopharmacology is headquartered

Location

Headquarters

HQ city
Brentwood
HQ country
United States
HQ region
North America

Offices1 record

Markets served

American Society of Clinical Psychopharmacology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Membership Dues: ASCP generates revenue through annual membership dues at tiered rates: $125 for Regular Membership, $94 for Associate Membership, and complimentary for Residents/Trainees. Multi-year renewals offer 5% off three-year and 10% off five-year commitments. Member referral program provides $10 discount for both referrer and new member.
  2. Annual Meeting Registration and Sponsorships: The ASCP Annual Meeting generates revenue through attendee registration fees (with discounted rates for members) and corporate sponsorships. The 2025 meeting had 958 total attendees with representation from academic, research, industry, and clinical sectors. Sponsorships range from Platinum to Silver levels.
  3. Educational Products and Publications: ASCP sells educational products including the Interactive AI Curriculum in Psychopharmacology. The society's official journal The Journal of Clinical Psychiatry provides member subscriptions (valued at $199) as a membership benefit, with circulation managed through Physicians Postgraduate Press.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualRegular Membership for doctoral-level professionals
SubscriptionAnnualAssociate Membership for non-doctoral professionals
FreemiumAnnualResident/Trainee Membership
SubscriptionAnnualFellow Membership recognition
SubscriptionMulti-year contractMulti-Year Renewal Discounts
SubscriptionAnnualDeveloping Countries Membership Rate

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

American Society of Clinical Psychopharmacology product offering

Product offering

Core offering

ASCP is a nonprofit professional medical society that advances the science, practice, and education of clinical psychopharmacology. It sells tiered individual memberships and delivers continuing education through its flagship Annual Meeting, the Interactive AI Curriculum in Psychopharmacology for psychiatry residents, the Journal of Clinical Psychiatry, podcasts, problem-based learning modules, clinical trials resources, and award programs for early-career investigators.

Product overview

The American Society of Clinical Psychopharmacology (ASCP) is a professional membership organization rather than a software product company. ASCP offers a portfolio of educational and professional development services centered around advancing clinical psychopharmacology. Core offerings include the ASCP Annual Meeting (the premier psychopharmacology conference), the ASCP Interactive AI Curriculum for psychiatry residency training, the Psychopharm Today Podcast (collaboration with Psychiatric Times), and the Find a Psychopharmacologist Database. Additional services include the ASCP Job Board, Clinical Trials Support with trial listings, The Journal of Clinical Psychiatry (official journal with ASCP Corner), 5 Minute Pearls video series, Problem-Based Learning cases, the Nina Schooler Early Career Research Award ($7,500), the New Investigator Award Program, the Alcohol Clinical Trials Initiative (ACTIVE), and the ASCP Deprescribing Consensus Statement. The society does not offer a unified software product platform but provides these professional resources and educational materials to its over 900 members.

Differentiator

Problem solved

Functional benefit

Brands

  • The Journal of Clinical Psychiatry: ASCP's official journal with the largest circulation in psychiatry, published by Physicians Postgraduate Press (PPP).
  • Psychopharm Today Podcast
  • Psychopharm Today
  • ASCP Interactive AI Curriculum
  • Nina Schooler Early Career Research Award
  • Donald Klein Lifetime Achievement Award
  • Paul Wender Best Paper Award
  • Henry Nasrallah Award
  • ACTIVE (Alcohol Clinical Trials Initiative)
  • ASCP Corner
  • 5 Minute Pearls in Psychopharmacology
  • Problem-Based Learning in Psychopharmacology

Products and services

  • ASCP Membership
  • ASCP Annual Meeting

Quantifiable outcome

  • 45 international experts achieved consensus on 63% of evaluated clinical scenarios in landmark deprescribing study
  • +1 more outcomes

Companies that use American Society of Clinical Psychopharmacology

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

American Society of Clinical Psychopharmacology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

American Society of Clinical Psychopharmacology partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, major and minor.

  • The Journal of Clinical Psychiatry (Physicians Postgraduate Press)coreStrategic or Co-development PartnerThe Journal of Clinical Psychiatry, published by Physicians Postgraduate Press (PPP), is ASCP's official journal with the largest circulation in psychiatry. Each month the Journal features the 'ASCP Corner.' Current ASCP members receive a free online subscription to the JCP as part of their membership.
  • American Brain Coalition (ABC)coreStrategic or Co-development PartnerASCP is a proud member of the American Brain Coalition (ABC), supporting advocacy for brain research and neurological and psychiatric disorders.
  • American College of Neuropsychopharmacology (ACNP)majorStrategic or Co-development PartnerASCP participated in developing a portion of ACNP's annual meeting, emphasizing the science of clinical psychopharmacology. ASCP took over development of the ACNP curriculum for residents in psychopharmacology in 1997, which is now widely used in the U.S. and internationally.
  • National Institute of Mental Health (NIMH)coreStrategic or Co-development PartnerASCP is joined by NIMH to organize the Annual Meeting program that emphasizes presentation of information not previously published or presented. NIMH representatives participate in the Program Committee.
  • National Institute on Drug Abuse (NIDA)coreStrategic or Co-development PartnerASCP collaborates with NIDA on the Annual Meeting program and participates in the Clinical Trials Workshop sponsored in conjunction with NIMH and Zucker Hillside Hospital.
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)coreStrategic or Co-development PartnerASCP partners with NIAAA on the Annual Meeting program, with NIAAA representatives included in program planning and federal agency updates.
  • Food and Drug Administration (FDA)coreStrategic or Co-development PartnerFDA representatives participate in the ASCP Annual Meeting Program Committee, with the FDA Center for Drug Evaluation and Research having dedicated representation. FDA regulatory perspectives are featured in meeting sessions.
  • ACTIVE (Alcohol Clinical Trials Initiative) SupportersmajorStrategic or Co-development PartnerACTIVE workgroup includes two representatives from each supporting corporation, FDA, NIDA, academic experts, and NIAAA consultation. Current supporters: Imbrium, Lilly. Past supporters include Abbott, Alkermes, Arbor Pharmaceuticals, Dicerna, Ethypharm, GlaxoSmithKline, Indivior, Janssen, Kinnov Therapeutics, Lundbeck, Mitsubishi Tanabe Pharma, Otsuka, Pear Therapeutics, Pfizer, Schering Plough.
  • Psychiatric TimesmajorGTM or Marketing PartnerASCP partners with Psychiatric Times on the Psychopharm Today podcast, expanding offerings and bringing expert-driven conversations to the community. Members can opt for free Psychiatric Times delivery.
  • International Foundation for Research and Education on Depression (iFred)minorStrategic or Co-development PartneriFred (depression.org), led by ASCP founder Dr. Paul Wender, shares educational information on depression. ASCP links to iFred resources from its patient information section.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

American Society of Clinical Psychopharmacology competitors and assessment

Company assessment

Broad incumbents

Regional players

  • European College of Neuropsychopharmacology (ECNP): European counterpart to ACNP/ASCP focused on neuropsychopharmacology research and education. Comparable membership society model with annual scientific meeting and educational programs; primarily Europe-based.

Emerging players

  • International Society for Affective Disorders (ISAD): Scientific society focused on mood disorders — a condition class central to ASCP's clinical content (deprescribing consensus covers antidepressants). Comparable academic society model but narrower scope.
  • Anxiety and Depression Association of America (ADAA): Patient-and-professional organization with overlapping focus on psychopharmacology of anxiety/depression. Smaller and less academic than ASCP, but addresses the same therapeutic conditions ASCP's consensus work covers.

Others

  • American College of Physicians (ACP): Large internal medicine society whose CME/CE infrastructure and journal model (Annals of Internal Medicine) parallels the operational template ASCP uses for the Journal of Clinical Psychiatry membership benefit.

Direct peers

  • American College of Neuropsychopharmacology (ACNP): The closest direct peer to ASCP — both are physician-led scientific societies advancing psychopharmacology and neuropsychopharmacology. ACNP actually handed off Model Curriculum development to ASCP in 1997, evidencing tight functional overlap.
  • Society of Biological Psychiatry (SOBP): Scientific society for biological psychiatry with overlapping membership of clinical investigators and psychiatrists focused on pharmacology and treatment research. Comparable annual scientific meeting and journal model.
  • International College of Neuropsychopharmacology (CINP): Global scientific organization for neuropsychopharmacology. Comparable to ASCP in mission and target membership (psychiatrists and clinical investigators), with international rather than U.S.-centric focus.
  • American College of Psychiatrists: Honor-focused psychiatric professional society emphasizing education, research, and clinical excellence — overlapping strongly with ASCP's education-and-consensus mission and target audience of senior psychiatrists.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

American Society of Clinical Psychopharmacology social profiles

Digital presence

American Society of Clinical Psychopharmacology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

American Society of Clinical Psychopharmacology leadership team

Management profile

Number of profiles

Profiles7 records

American Society of Clinical Psychopharmacology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

American Society of Clinical Psychopharmacology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Society of Clinical Psychopharmacology

What does American Society of Clinical Psychopharmacology do?

ASCP is a nonprofit professional medical society that advances the science, practice, and education of clinical psychopharmacology. It sells tiered individual memberships and delivers continuing education through its flagship Annual Meeting, the Interactive AI Curriculum in Psychopharmacology for psychiatry residents, the Journal of Clinical Psychiatry, podcasts, problem-based learning modules, clinical trials resources, and award programs for early-career investigators.

Is American Society of Clinical Psychopharmacology a public or private company?

American Society of Clinical Psychopharmacology is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was American Society of Clinical Psychopharmacology founded?

American Society of Clinical Psychopharmacology was founded in 1992. It employs 1 to 10 people.

Where is American Society of Clinical Psychopharmacology based?

American Society of Clinical Psychopharmacology is headquartered in Brentwood, United States, in the North America region.

How does American Society of Clinical Psychopharmacology make money?

Three revenue lines are on record. Membership Dues are the primary driver. The others are annual Meeting Registration and Sponsorships and educational Products and Publications.

Who are American Society of Clinical Psychopharmacology's main competitors?

Broad incumbents on record are American Academy of Child and Adolescent Psychiatry (AACAP) and American Psychiatric Association (APA). European College of Neuropsychopharmacology (ECNP) is listed as a regional player. Emerging players are International Society for Affective Disorders (ISAD) and Anxiety and Depression Association of America (ADAA). American College of Physicians (ACP) is listed as an others. Direct peers are American College of Neuropsychopharmacology (ACNP), Society of Biological Psychiatry (SOBP), International College of Neuropsychopharmacology (CINP) and American College of Psychiatrists.

Does American Society of Clinical Psychopharmacology have an API?

No public API is recorded for American Society of Clinical Psychopharmacology.

What industry is American Society of Clinical Psychopharmacology in?

American Society of Clinical Psychopharmacology's product category is Professional Medical Society (Clinical Psychopharmacology). Its primary akta.pro industry code is EDADACAF, Continuing Education (CE/CPD) & Provider Accreditation Bodies, with a secondary code of EDAOAJAO, Clinical Research Support (CRC/CTA). Its NAICS code is 6113 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBraeburn Presents New Data at 2026 ASCP Annual Meeting Demonstrating Opioid Withdrawal Suppression at Low Buprenorphine Plasma ConcentrationsBraeburn Inc. presented three poster studies at the 2026 American Society of Clinical Psychopharmacology Annual Meeting in Miami, Florida, showcasing clinical and real-world evidence for BRIXADI (buprenorphine) extended-release injection in treating opioid use disorder. A post-hoc analysis found opioid withdrawal suppression was sustained even at buprenorphine plasma concentrations below 0.5 ng/mL, while a retrospective cohort study demonstrated higher treatment retention rates for BRIXADI compared to sublingual buprenorphine at 6 months (20.4% vs 7.2%). Real-world specialty pharmacy data covering over 30,000 patients revealed evolving utilization patterns, with 60.8% of BRIXADI Weekly initiators later switching to Monthly formulations.EIN PresswireLandmark International Consensus Defines When and How to Safely Deprescribe Psychotropic Medications in Mood DisordersA task force from the American Society of Clinical Psychopharmacology published a landmark international consensus study establishing clinical guidance for safely deprescribing psychotropic medications in patients with mood disorders, using a Delphi process with 45 international experts that achieved consensus on 63% of evaluated clinical scenarios. The study provides evidence-informed recommendations on when to discontinue or maintain antidepressants, antipsychotics, benzodiazepines, and Z-drugs based on factors such as treatment response, relapse risk, side effects, and patient-specific circumstances. The authors call for randomized discontinuation trials and prospective studies to address remaining evidence gaps identified in the consensus framework.Psychedelic AlphaGilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive Disorder StudyGilgamesh Pharmaceuticals reported positive top-line data from its Phase 2a study of GM-2505 for major depressive disorder, showing rapid and sustained antidepressant effects with significant separation from the control group. The treatment demonstrated high remission rates, reaching 94% by Day 29 in the higher dose arm, with results to be presented at the American Society of Clinical Psychopharmacology meeting.GlobeNewswireTonix Pharmaceuticals Announces Presentation of Data Supporting Development of Racemic and Single (S)-Isomer Tianeptine, Plastogen Anti-Depressants, at the American Society of Clinical PsychopharmacolTonix Pharmaceuticals presented data on tianeptine's mechanism and pharmacokinetics at the ASCP meeting, supporting its development as a plastogen. The (S)-isomer, free from µ-opioid activity, is in preclinical development for depression, Alzheimer's, and Parkinson's. Interim analysis of the Phase 2 trial for major depressive disorder is expected in Q4 2023.GlobeNewswireCerevance Announces Oral Presentation of Phase 1 Data on CVN766 at American Society of Clinical Psychopharmacology (ASCP)Cerevance will present Phase 1 data on CVN766 at the ASCP conference in Miami, May 30–June 2, 2023. The oral presentation highlights favorable safety and tolerability with no somnolence, supporting CVN766's potential to treat negative and cognitive symptoms in schizophrenia.AxialtxAxial Biotherapeutics to Present Virtual Presentation at American Society of Clinical Psychopharmacology (ASCP) 2020 Annual MeetingAxial Biotherapeutics will present a virtual session at the ASCP 2020 Annual Meeting on May 30, 2020, detailing its gut-brain axis approach to CNS therapeutics. The company's pipeline includes lead programs for Autism Spectrum Disorder and Parkinson's Disease, with preclinical work in other areas.PsychiatristBlood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task ForceThe American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force have issued a joint consensus statement providing guidelines for using therapeutic drug monitoring (TDM) to optimize antipsychotic treatment. The document outlines clinical indications, sampling times, and reference ranges to help clinicians improve the efficacy and safety of these medications in various patient subgroups.GlobeNewswireOpiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual MeetingOpiant Pharmaceuticals' CEO Roger Crystal and Chief Scientific Officer Phil Skolnick will participate in a panel at the ASCP 2018 Annual Meeting in Miami Beach, with Skolnick chairing a session on the opioid epidemic. ASCP will present the 2018 Donald Klein Lifetime Achievement Award to Skolnick for his contributions to neuropsychopharmacology.GlobeNewswireAxsome Therapeutics to Present Data on AXS-05 at the 2018 American Society of Clinical Psychopharmacology Annual MeetingAxsome Therapeutics will present Phase 1 pharmacokinetic and mechanism-of-action data for AXS-05 at the 2018 ASCP meeting in Miami on May 31. The data will show similarities to ketamine and target CNS receptors, with AXS-05 in Phase 3 trials for treatment-resistant depression and Phase 2/3 for Alzheimer's agitation.GlobeNewswireTonix Pharmaceuticals to Present at the 2018 American Society of Clinical PsychopharmacologyTonix Pharmaceuticals announced that its CMO, Gregory Sullivan, will present at the 2018 ASCP Annual Meeting in Miami Beach. The presentation covers TNX-102 SL, a bedtime treatment for PTSD, with Phase 3 development underway. The company also mentioned TNX-601 and TNX-801 in pre-IND stages.